Ixazomib in addition to chemotherapy for the treatment of acute myeloid leukemia in older adults.
Saved in:
| Title: | Ixazomib in addition to chemotherapy for the treatment of acute myeloid leukemia in older adults. |
|---|---|
| Authors: | Amrein PC; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA., Preffer FI; Immunopathology, Massachusetts General Hospital, Boston, MA, USA., Fell G; Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Attar EC; Aprea Therapeutics, Inc, Boston, MA, USA., Narayan R; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA., Blonquist TM; Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Brunner AM; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA., Hobbs GS; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA., Hock HR; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA., McAfee SL; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA., Moran JA; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA., Bergeron MK; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA., Foster JE; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA., Bertoli C; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA., McGregor K; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA., Connolly C; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA., Behnan TT; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA., Som TT; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA., Ramos AY; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA., Vartanian MK; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA., Lombardi Story J; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA., Neuberg DS; Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Fathi AT; Leukemia Center, Massachusetts General Hospital, Boston, MA, USA. |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2025 Jul; Vol. 66 (7), pp. 1234-1244. Date of Electronic Publication: 2025 Mar 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
